The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a…
December 20, 2021 - 12 minutes
Idorsia
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
April 21, 2020 - 3 minutes
Top Cardiology Biotech News from the ESC Conference 2019
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
September 5, 2019 - 4 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
May 21, 2019 - 12 minutes
Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage
Idorsia will start a Phase III trial to study the efficacy of its drug in…
June 18, 2018 - 2 minutes
Actelion’s Billion-Euro Spin-Off Starts First Phase III Trial in its Pipeline
Idorsia has started the first Phase III study in its pipeline to test the drug…
May 16, 2018 - 3 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
March 8, 2018 - 8 minutes
How is Actelion Spin-Off Idorsia Doing One Year Later?
Actelion's spin-off Idorsia was blessed with a large pipeline and a healthy bank balance. How…
March 1, 2018 - 3 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
January 9, 2018 - 5 minutes
Actelion Spin Out and Roche Join Forces to Develop Cancer Immunotherapies
Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive…
December 20, 2017 - 2 minutes
Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could…
December 4, 2017 - 3 minutes
